Pfizer’s Trumenba Approval To Ignite EU Marketing Battle
Executive Summary
Another meningitis vaccine from Pfizer has been cleared for marketing in Europe, completing the company's portfolio and providing competition to GSK’s growing vaccines business.
You may also be interested in...
From Witty To Walmsley – The Priorities For GSK's New CEO
It's Emma Walmsley's first week at the helm of GlaxoSmithKline. What can we expect in terms of her priorities?
Pipeline Watch: Phase III Success With Emicizumab, Plecanatide And Sotagliflozin
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.